Chronic intrathecal immunoglobulin (Ig) production is with other inflammatory or non-inflammatory diseases, produced IgGs specific for C. pneumoniae intrathecally a hallmark of multiple sclerosis characterized by the (definite multiple sclerosis versus other inflammatory presence of oligoclonal IgGs and, in addition, polyspecific neurological diseases: P ⍧ 0.027). The presence of recognition of different pathogens such as measles, intrathecal IgGs to C. pneumoniae was independent of rubella and herpes zoster virus. While the antigen the duration of disease and relatively stable over time. specificity of the oligoclonal IgGs in multiple sclerosis
Introduction
Both infectious agents and pathological autoimmune reactions the Chlamydia hypothesis. The number of patients studied in these scattered reports was small, and data were based to CNS antigens have been implicated in the aetiology mainly on PCR analysis (Boman et al., 2000 ; Hammerschlag of multiple sclerosis (Noseworthy et al., 2000) . Recent et al., 2000; Layh-Schmitt et al., 2000; Li et al., 2000 ; Pucci neuropathological data have not only provided evidence Treib et al., 2000) . However, the PCR detection an important role of anti-myelin autoantibodies (Genain et al., of C. pneumoniae in the CSF is not standardized and the 1999), but have also pointed to a considerable immunocontradictory results might be explained by different PCR pathological heterogeneity of multiple sclerosis (Lucchinetti protocols, different strategies to extract DNA, different et al., 1998) . Specifically, two patterns of multiple sclerosis handling of the CSF, the amount of CSF drawn, the cell plaques were identified that would be consistent with number in the CSF and other variations. infectious or toxin-induced demyelination (Lucchinetti et al., On the basis of experience with other infectious CNS 2000). The pathogenetic heterogeneity of multiple sclerosis diseases, it is evident that a negative PCR in the CSF does has obvious therapeutic consequences.
not exclude an infectious agent as a cause of disease. For An infectious aetiology of multiple sclerosis has been example, in herpes simplex encephalitis, the PCR is positive suspected for more than a century, and over the years a large only at the beginning of the disease. After~2 weeks, the number of different viruses have been linked to it (Meinl, PCR is usually negative, but the diagnosis can be established 1999). To confuse matters further, anti-viral immune retrospectively by specific IgG production to herpes simplex responses, including intrathecal antibody production to such virus and by specific reactivity of oligoclonal bands to this common pathogens as measles, rubella and herpes zoster virus assessed by isoelectric focusing (IEF) with subsequent viruses, are quite common in multiple sclerosis patients.
affinity-mediated immunoblot (IEF-western blot). This These polyspecific anti-viral IgGs do not correspond to the serological feature is very stable and reliable (Sauerbrei et al., major oligoclonal IgG bands of the CSF and are considered as 2000). Likewise, in neuroborreliosis, the diagnostic sensitivity a bystander reaction [measles-rubella-zoster (MRZ) reaction] of the PCR from CSF was estimated to be just 17%, and the (Sindic et al., 1994; Luxton et al., 1995; diagnosis is based routinely on an intrathecal IgG production 1998). Furthermore, patients with multiple sclerosis have to Borrelia burgdorferi (Lebech et al., 2000) . predominantly low-affinity antibodies against these pathogens
The aim of our present study was to test the Chlamydia in the CSF, whilst patients with a primary viral infection have hypothesis. We studied a total of 120 patients, using a predominantly high-affinity antibodies against the causative combination of techniques, including conventional serology, organism (Luxton et al., 1995) .
IEF-western blot and PCR. Immunoglobulins are stable Very recently, Chlamydia pneumoniae has been linked to outside the body and the experiments are not affected by the multiple sclerosis. Sriram and colleagues reported on a amount of CSF obtained and the speed of further processing. multiple sclerosis patient who failed to respond to Most importantly, if C. pneumoniae infection was pathoimmunosuppressive treatment, but had C. pneumoniae in the genetically relevant, it would be expected that the major CSF CSF and improved dramatically after antibiotic treatment oligoclonal bands are directed to this pathogen (Gilden, 1999) . (Sriram et al., 1998) . In a larger cross-sectional study, the We found that an intrathecal IgG production to same group reported that C. pneumoniae could be cultured C. pneumoniae is indeed more common in multiple sclerosis from 64% of multiple sclerosis patients versus 11% of patients than controls. However, in contrast to a previous controls, and polymerase chain reaction (PCR) allowed the report (Sriram et al., 1999) , all our PCR results were negative. detection of the C. pneumoniae genome in 97% of multiple More importantly, we report that in multiple sclerosis sclerosis patients versus 18% of controls with other patients, the major CSF oligoclonal bands are not directed to neurological diseases (OND) (Sriram et al., 1999) .
C. pneumoniae as assessed by IEF-western blot. This is in Chlamydia pneumoniae is an obligate intracellular striking contrast to another chronic bacterial CNS infection, bacterium that infects alveolar macrophages, monocytes and neuroborreliosis, where IEF-western blot analysis revealed a endothelial cells. Serology indicates that about half of the strong reactivity of B. burgdorferi-specific oligoclonal bands. population in developed countries have had contact with Taken together, our results suggest that the intrathecal immune C. pneumoniae (Hargreaves et al., 1994) . Chlamydia bacteria response to C. pneumoniae in multiple sclerosis is probably have been linked to a chronic encephalopathy in cows, which a bystander reaction, very similar to the well-known MRZ is called sporadic bovine encephalomyelitis (Harshfield, 1970; reaction (Reiber et al., 1998) . Sriram et al., 1998) . If C. pneumoniae were linked to the pathogenesis of certain subtypes of multiple sclerosis, this
Material and methods
would have striking therapeutic consequences. Indeed, based on previous results (Sriram et al., 1999) , clinical trials of Patients antibiotic therapy are now underway (Treib et al., 2000) .
Paired serum and CSF samples from a total of 120 patients Several contradictory brief reports, mostly in the form of were analysed. Of these, 12 patients were diagnosed as possible multiple sclerosis, 35 as relapsing-remitting (RR) letters, have appeared in the meantime, shedding doubt on multiple sclerosis and 10 as chronic progressive (CP)-multiple serum) in 50 ml tissue culture flasks. For infection, the monolayers were centrifuged with 5 ϫ 10 7 infection forming sclerosis (Poser et al., 1983) . Thirty-five patients with diseases units of C. pneumoniae (strain HK) in 6 ml of PBS (phosphatesuch as viral encephalitis, Guillain-Barré syndrome, meninbuffered saline). Cells and C. pneumoniae were centrifuged gitis and chronic inflammatory demyelinating polyneuropathy for 30 min at 2000 g and 37°C. After centrifugation, the were classified as other inflammatory neurological diseases supernatant was substituted with OptiMEM supplemented (OIND). Twenty-seven patients with diseases such as disc with 10% FCS. After 3-5 days in culture (5% CO 2 ), prolapse, headache, vertigo and cerebral infarct were C. pneumoniae was harvested. After careful abrasion of the classified as OND ( between the 40 and 44% phase, which contains the reticular bodies of strain TW-183 were used as antigen. In a recent bodies, and that between the 44 and 52% phase, which comparative analysis, this ELISA performed well in comparcontains the elementary bodies, were aspirated. In a third ison with complement fixation and microimmunofluorescence ultracentrifugation step (17 500 r.p.m., 5°C, 50 min), the (Persson and Boman, 2000) . Seropositivity was assessed remaining Urografin was removed. The resulting sediment according to the instructions of the manufacturer using a was resuspended in PBS and stored at -80°C until further 1 : 100 dilution of the serum. To determine the presence of use. The elementary body preparation of C. pneumoniae was anti-C. pneumoniae IgGs in the CSF, the spinal fluid was tested for its quality by microimmunofluorescence assay with diluted 1 : 2. Analogously to evaluation of serum samples, positive and negative control sera. In addition PCR was CSF samples were scored positive for C. pneumoniae if the performed to exclude mycoplasma contamination of cell optical density (OD) was at least twice the negative control, culture. To break up the reticular and elementary bodies, the which was measured around an OD of 0.2.
antigen preparation was boiled for 20 min in a buffer To assess the presence of an intrathecal IgG production containing 1% sodium dodecylsulphate, 2.5% 2-ME (2-against C. pneumoniae, CSF was diluted 1 : 2 and the mercaptoethanol), 0.5 mM EDTA (ethylene diamine tetracorresponding serum was diluted to the same concentration acetic acid) and 31 mM Tris, pH 6.8. Borrelia burgdorferi strain PKo, a German skin isolate, of IgGs. The specific intrathecal IgG production antibody was cultivated at 33°C in modified Kelly medium (Preacindex (AI) was then calculated as AI ϭ OD CSF : OD serum . In Mursic et al., 1991) . Washed borreliae (three times in PBS the case of an intrathecal IgG production, the corrected AI with 0.005 M MgCl 2 ) were sonicated for 3 min using a was calculated as AI ϫ Q IgG /Q lim . Q lim was calculated as Branson Sonifier, Cell disruptor B15, microtip 5 mm described (Reiber and Lange, 1991 ). An AI Ͼ 2 was (Branson, Danburry, Conn., USA) on ice. The sonicate was considered to indicate a significant and reliable intrathecal controlled for complete destruction of the borrelia cells by IgG production against the pathogen studied. dark field microscopy. The protein content of the sonicate was determined by the method of Bradford (Bradford, 1976) .
Culture and processing of C. pneumoniae and B. burgdorferi IEF gels
Buffalo green monkey kidney cells were cultured in An IEF of Ig in the CSF can be performed in an agarose or a polyacrylamide gel. Agarose gels are more suitable for OptiMEM medium supplemented with 10% FCS (foetal calf affinity-mediated transfer, but polyacrylamide gels allow a to visualize the oligoclonal bands with this method. The gels were run according to the manufacturer's instructions. Briefly, better resolution of individual bands. Since the purpose of this part of the study was to perform a sensitive IEF-western 20 µl of serum and CSF diluted to an IgG concentration of 0.02 mg/ml were added on sample application pieces located blot analysis, agarose gels were chosen for these experiments. In addition, oligoclonal banding was revealed in a subset of 4 cm from the anode. The gel was run for 1.5 h at 1500 V and 10°C. Subsequently, proteins were silver stained as patients using polyacrylamide gels.
To perform the IEF in agarose gels, unconcentrated CSF described (Wurster, 1983) . and serum were applied to an IEF gel pH 3-10 according to the manufacturer's guidelines (Titan Gel Electrophoresis Kit;
PCR to detect C. pneumoniae genome in the Helena BioSciences, UK). All agarose IEF gels were run CSF under the same conditions. Briefly, the IgGs in CSF were CSF samples from 23 patients were analysed by nested PCR diluted to 50 µg/ml in 0.9% NaCl if they had a concentration for the presence of C. pneumoniae. DNA of 100 µl of CSF Ͼ50 µg/ml, and were used undiluted if they had a was extracted and purified using the Qiagen DNA extraction concentration Ͻ50 µg/ml. The IgG in the serum was diluted kit according to the manufacturer's instructions. DNA was to the respective CSF concentration. A 5 µl aliquot of the eluted into 200 µl of buffer AE (Qiagen, Hilden, Germany). dilutions of CSF and serum was used for the IEF gel. After A 5 µl aliquot was subjected to a nested PCR, amplifying focusing, the gels were blotted on nitrocellulose paper for DNA for 16S rRNA of C. pneumoniae. Briefly, in the first 30 min with a weight of 1 kg. The blotted IgGs were detected PCR, an 828 bp (base pair) fragment was amplified (primers: with HRP (horseradish peroxidase)-coupled anti-human IgG 5Ј-GCT GGC GGC GTG GAT G-3Ј and 5Ј-CGA CAC GGA and enhanced chemiluminescence (ECL).
TGG GGT TG-3Ј; 30 cycles of denaturing at 94°C for 30 s, To determine the antigen specificity of oligoclonal bands in annealing at 60°C for 60 s and elongation at 72°C for 90 s). the CSF, IEF and a subsequent affinity-mediated immunoblot
In the second PCR, a 570 bp product was reamplified from were performed. To this end, the nitrocellulose paper was this fragment (primers 5Ј-TGG CGG AAG GGT TAG TAG coated with 10 µg/ml antigen (5 ml/12 cm 2 ) (C. pneumoniae TA-3Ј and 5Ј-CCC TTT TCC CCA TCT ATC C-3Ј; 30 or B. burgdorferi) in 0.1 M carbonate buffer pH 9.5 overnight cycles of denaturing at 94°C for 30 s, annealing at 68°C for at 4°C before blotting. To block non-specific binding, the 60 s and elongation at 72°C for 60 s). PCR products were nitrocellulose paper was incubated subsequently in 10% lowvisualized by gel electrophoresis. fat milk powder for 1 h at room temperature. As control, a part of the membrane was coated only with 10% milk powder for 1 h at room temperature. The IEF-western blot protocol
Results
was adjusted such that no IgGs blotted to the membrane Seroprevalence and intrathecal production of coated with milk powder. After blotting, the IgGs were detected with anti-human IgG-peroxidase (supplied with the IgGs specific for C. pneumoniae First, we screened all patients and controls for the presence kit) or goat anti-human IgG-biotin (Sigma) and streptavidinperoxidase (Jackson). Anti-human IgG-peroxidase was used or absence of a serum and CSF IgG response to C. pneumoniae. The proportion of seropositive patients was to detect B. burgdorferi-specific oligoclonal bands. For detection of C. pneumoniae-specific oligoclonal bands, the similar in the multiple sclerosis and control groups:~50% of all studied patients showed serological evidence of prior sensitivity had to be increased and the biotin-streptavidin system was used. Using this biotin-streptavidin system, the infection with C. pneumoniae (Table 1) . In this regard, there was no difference between multiple sclerosis patients and sensitivity could be increased by a factor of~10. The blots were developed with the ECL system. The signals were controls. Sixty patients were seropositive for C. pneumoniae. Out of these, 37% had anti-C. pneumoniae IgGs in the CSF. detected with X-ray films or the LAS 1000 (Fuji, Straubenhardt, Germany). For pI determination, a calibration
The ELISA was not sensitive enough to detect transudation of IgGs into the CSF of marginally seropositive patients. kit from Amersham Pharmacia, UK was used. The marker was stained in the agarose gel with Coomassie blue.
Conversely, among the 15 patients identified with an intrathecal IgG production to C. pneumoniae, 11 scored To validate the quality of the antigen and the coating procedure, a dot-blot assay was performed. To this end, 2.5 positive for anti-C. pneumoniae IgGs in the serum. In contrast, 26% of patients with RR-multiple sclerosis µg of the antigen preparation were dotted on the membrane. After the spot had dried, the membrane was blocked with and 20% of those with CP-multiple sclerosis (mean ϭ 24% for all patients with definite multiple sclerosis), but only 6% 10% milk powder for 1 h at room temperature. Then the membrane was incubated with different dilutions of sera for of the OIND and 4% of the OND patients showed an intrathecal IgG production to C. pneumoniae (Table 1) . The 30 min at room temperature. Bound IgGs were detected with goat anti-human-peroxidase and the blot was developed specific AI in all patients with an intrathecal IgG response to C. pneumoniae was between 2.1 and 8, with a mean AI with ECL.
IEF was also performed in polyacrylamide gels (Amersham of 3.86. The difference between the proportion of patients with intrathecal IgG response to C. pneumoniae in the definite Pharmacia Biotech, Uppsala, Sweden) in a subset of patients Fig. 1 Lack of reactivity of multiple sclerosis oligoclonal bands to C. pneumoniae. In A and the left panel of B, CSF and serum of two multiple sclerosis patients were analysed by IEF-western blot. Both patients had an intrathecal IgG production to C. pneumoniae detected by ELISA. Patient GCe (A) (AI ϭ 4.6) did not show any reactivity to C. pneumoniae in the IEF-western blot, while patient KoYu (B) (AI ϭ 2.4) displayed a weak reactivity that seemed to be distinct from the major oligoclonal bands. The membranes were coated with C. pneumoniae or milk powder as indicated. Immunoglobulin, which was affinity-blotted to the coated membranes, was detected with anti-human IgG-biotin, streptavidin-peroxidase and ECL. The immunoglobulins blotted to the uncoated membranes were detected with the less sensitive system of applying anti-human IgG-peroxidase and ECL. IEF markers, which are indicated on the left in B, were stained in the gel with Coomassie blue. The left panel in A and the right panel in B show serum and CSF of the respective patients in silver-stained IEF polyacrylamide gels. The region between pH 9.3 (indicated by the presence of cystatin C in the CSF) and pH 6.5 is shown. IgG response to C. pneumoniae.
CSF and serum of a patient with definite RR-multiple sclerosis was analysed for IgG against different viral antigens and C. pneumoniae at two different time points by ELISA. The
Stability of the antigen-specific intrathecal IgG
corrected AIs that describe the intrathecally produced IgG against production over time the different pathogens are shown.
We assessed the temporal stability of anti-C. pneumoniae IgGs by repeat CSF analysis in nine patients. The time interval between the two CSF collections ranged from 3 weeks to 8 months. Five of these nine patients showed an intrathecal IgG response) remained unchanged over the observation period. In eight of the nine cases, the quantitative intrathecal IgG production to C. pneumoniae. In all nine patients, the responder status (i.e. presence or absence of an specific AI to C. pneumoniae was very stable over time. In Fig. 2 Weak reactivity to C. pneumoniae in special cases. In A (left panel), the IEF-western blot of patient PoVe (probable multiple sclerosis) with a high IgG response to C. pneumoniae in both serum and CSF, but without an intrathecal Ig production to C. pneumoniae (AI ϭ 1.3), is shown. Both serum and CSF react to C. pneumoniae by IEF-western blot. In B, the IEF-western blot of patient Hu.M. is shown. This patient, who suffered from a hypoglycaemic coma and a long-standing diabetes mellitus, had an intrathecal IgG production against C. pneumoniae. In the IEF-western blot analysis, IgG reactive to C. pneumoniae both in CSF and serum can be seen. The vertical line in A and B indicates that CSF and serum were run on different gels under the same focusing conditions. In A (left panel) and B, membranes were coated with C. pneumoniae with milk powder as control or were left uncoated. IgG was detected with anti-human IgG-biotin, streptavidin-peroxidase and ECL on coated membranes and with the less sensitive anti-human IgG-peroxidase on uncoated membranes. The right panel in A shows IEF of serum and CSF of patient PoVe in a silver-stained polyacrylamide gel. The region between pH 9.3 (indicated by the presence of cystatin C in the CSF) and pH 6.5 is shown.
one OIND patient, the corrected AI to C. pneumoniae dropped powder is used commonly as a blocking reagent and served here to control the specificity and evaluate unspecific transfer. from 8.1 to 3.4 after 5 months.
In one multiple sclerosis patient, we compared the time The analysis was done in all 15 samples with an intrathecal IgG production to C. pneumoniae (Table 1) , in three samples course of C. pneumoniae-specific IgGs with the reactivity against several other infectious agents (measles, rubella, with a high C. pneumoniae-specific OD in the ELISA in both serum and CSF and additionally as a control in eight samples varicella zoster, cytomegalovirus and herpes simplex virus). This patient, who had had clinically definite RR-multiple without anti-C. pneumoniae IgGs as assessed by ELISA. Eleven of the 15 patients with an intrathecal IgG production sclerosis for 12 years, had elevated AIs to all these agents. This type of response has been described as the MRZ reaction to C. pneumoniae had definite multiple sclerosis. In none of these 11 multiple sclerosis patients were the oligoclonal (Reiber et al., 1998) . CSF was obtained at two time points, 6 months apart. After the first CSF sample revealed an bands in the CSF specific for C. pneumoniae. Ten of them did not show any specific response to C. pneumoniae in the intrathecal IgG response to C. pneumoniae, the patient was treated with doxycycline (200 mg per day orally) for 2 weeks.
IEF-western blot. A representative example is shown in Fig. 1A . In one of these 11 patients, weak reactivity to As shown in Table 2 , all AIs remained essentially unchanged. Together, the results show that the intrathecal immune C. pneumoniae was evident by IEF-western blot (Fig. 1B) . Two of the four control patients with an intrathecal response to C. pneumoniae, as well as to other infectious agents, is quite stable over time.
IgG production to C. pneumoniae displayed reactivity to C. pneumoniae in the IEF-western blot. One representative example (patient Hu.M.) of these two is shown (Fig. 2B ). This patient presented with hypoglycaemic coma, having a
Antigen specificity of oligoclonal bands
Next, we tested the antigen specificity of CSF oligoclonal 32-year history of type 1 diabetes. PCR to detect C. pneumoniae in the CSF was not done in this patient. The bands by IEF-western blotting, using C. pneumoniae, B. burgdorferi and milk powder as antigens. Low-fat milk other patient (N.M.) was diagnosed with limbic encephalitis of unknown origin and focal epileptic seizures. The CSF of this patient did not contain C. pneumoniae as assessed by PCR. It should be noted that the IEF-western blot reactivity in these patient samples was only detected by the very sensitive method of applying streptavidin-biotin. This indicates that only a small minority of the IgG in the CSF was directed against C. pneumoniae. Three patients with high reactivity in serum and CSF to C. pneumoniae by ELISA, but without an intrathecal IgG production to C. pneumoniae (AI ϭ 0.9, AI ϭ 1.0 and AI ϭ 1.3) were also analysed by IEF-western blot. Two of them (PoVe with probable multiple sclerosis, LuAl with definite CP-multiple sclerosis) showed reactivity in both serum and CSF in the C. pneumoniae-directed IEF-western blot. The third (ZiSa with RR-multiple sclerosis) did not react by IEFwestern blot. It is of note that IEF-western blot analysis also detected bands in the serum of patients PoVe and LuAl. Again, specificity of this reactivity was confirmed by using milk proteins and B. burgdorferi as control antigens (data not shown). One representative example (PoVe) is shown in Fig. 2A . The patient PoVe, who had probable multiple sclerosis, showed the strongest response to C. pneumoniae Fig. 3 Comparison of the IEF-western blot response to C. pneumoniae and B. burgdorferi using detection systems with by IEF-western blot. However, even in this patient, the very different sensitivities. CSF and serum of patient NB 3 (neurosensitive detection system was required (Fig. 3) . Importantly, have reactivity to C. pneumoniae in the CSF measured by ELISA. When these eight patients were analysed by IEFwestern blot for reactivity to C. pneumoniae, none of them example is shown in Fig. 4A . In one patient, the IEF-western blot reactivity to B. burgdorferi was detected in CSF only showed any reactivity even when evaluated with the highly sensitive detection system. (Fig. 4B) . In all four neuroborreliosis patients, B. burgdorferispecific oligoclonal IgG was readily detected with the less sensitive detection protocol using anti-human Ig-peroxidase,
Further evaluation of the IEF-western blot
whereas detection of reactivity to C. pneumoniae by IEFsystem and comparison with the immune western blot required the sensitive detection system (Fig. 3) . One of these neuroborreliosis patients was also examined for response to B. burgdorferi
To validate our IEF-western blot system further, we analysed C. pneumoniae cross-reactivity and did not react to this agent by IEF-western blot (data not shown). The B. burgdorferiserum-CSF pairs from patients with definite neuroborreliosis by IEF-western blot. The four control patients with specific IgG response in CSF was strong and distributed over a broad range of pI values (Figs 3 and 4 ). This makes a neuroborreliosis showed a strong intrathecal IgG production to B. burgdorferi with a mean AI of 43.4. direct comparison of the oligoclonal IgGs detected in the uncoated membrane with the B. burgdorferi-specific All four patients showed, as expected, B. burgdorferispecific oligoclonal IgGs in the CSF (Figs 3 and 4) . In oligoclonal IgGs difficult. This observation is in accordance with an earlier study of B. burgdorferi-specific oligoclonal addition, we analysed the reactivity of serum from the four patients to B. burgdorferi by IEF-western blot. In three IgGs in the CSF (Martin et al., 1988) . As reported in the previous section, most of the patients patients, B. burgdorferi-specific reactivity was observed by IEF-western blot in both serum and CSF. One representative who had an intrathecal IgG production to C. pneumoniae patients with definite RR multiple sclerosis, three from patients with definite CP-multiple sclerosis, five from patients with OIND and another five from OND patients were investigated. Using this method, C. pneumoniae was not detected in any of the 23 analysed CSF samples. One CSF sample from an OND patient initially gave a positive PCR signal in a first test but, since this could not be confirmed in two subsequent PCR assays of the same CSF sample, this material was scored negative.
Discussion
Our analysis of 120 paired CSF and serum samples from multiple sclerosis patients and controls revealed the following: (i) a positive serum IgG response to C. pneumoniae was observed in~50% of multiple sclerosis patients and controls;
(ii) in 20-25% of multiple sclerosis patients, but only 4-6% of controls, there is clear evidence for intrathecal synthesis of antibodies directed against C. pneumoniae; (iii) IEF- was similar. About 50% of the patients and controls were seropositive for C. pneumoniae. This is within the range of detectable by ELISA showed only weak or no reactivity of expected seropositivity in the normal population. For their oligoclonal bands to C. pneumoniae by IEF-western blot analysis, even with the sensitive technique. To exclude example, 43% of basic trainees of the US airforce had preinsufficient coating of the nitrocellulose membrane or existing antibodies to C. pneumoniae (formerly called TWAR alteration of the Chlamydia antigen during or after coating, strain) (Hargreaves et al., 1994) . This finding alone, that only we performed a series of additional experiments. First, CSF about half of the multiple sclerosis patients show serological IgGs of patients PoVe and Hu.M. reacted by IEF-western evidence of previous infection with C. pneumoniae, would blot to C. pneumoniae, but not to B. burgdorferi ( Fig. 2 and argue against a role for C. pneumoniae in all multiple data not shown). CSF of patient PoVe was run in parallel as sclerosis patients. a positive control in all IEF-western blot experiments
In contrast to the proportion of overall seropositivity, searching for C. pneumoniae reactivity. Secondly, to evaluate which was essentially identical between multiple sclerosis further the efficiency of binding of C. pneumoniae, patients and controls, there was a clear difference in the membranes were coated with C. pneumoniae and blocked proportion of patients with intrathecal antibody production with 10% milk powder as for the IEF-western blot, and to C. pneumoniae. In agreement with our results, another diluted serum samples were applied directly to the coated recent publication described a similar seropositivity in membranes without prior IEF separation. Subsequently, the multiple sclerosis patients versus controls and an intrathecal membranes were developed with the same detection system IgG production to C. pneumoniae in a subset of multiple as used for the IEF-western blot method. With this method, sclerosis patients. The authors did not detect any associareactivity of the serum samples that were positive by ELISA tion between disease activity and the immune response to could be detected at dilutions down to 1 : 30 000. The results C. pneumoniae (Krametter et al., 2001) . In their study, the of these experiments show that the C. pneumoniae antigens intrathecal IgG production to C. pneumoniae was associated bind efficiently to the nitrocellulose membrane and can be with elevated synthesis of total polyclonal IgG and correlated recognized readily by patients' antibodies.
with the intrathecal synthesis of virus-specific IgG (Krametter et al., 2001) . This finding raises the question as to whether in this subgroup of multiple sclerosis patients, C. pneumoniae
Presence of C. pneumoniae in the CSF
is directly linked to the pathogenesis or whether the intrathecal The presence of C. pneumoniae genome in the CSF was assessed by a sensitive nested PCR. Ten CSF samples from IgG production to C. pneumoniae is part of a bystander immune response known as the 'MRZ reaction' (Luxton part of a polyspecific activation of B cells in the CSF. et al., 1995; Reiber et al., 1998) .
Longitudinal analysis revealed that the intrathecal IgG production to measles, rubella and herpes zoster viruses, and
Specificity of oligoclonal IgGs in the CSF of
at a lower level also to cytomegalovirus, herpes simplex virus multiple sclerosis patients and C. pneumoniae, is quite stable over time. Furthermore, the Intrathecal IgG production and oligoclonal bands in the CSF polyspecific IgG response to measles, rubella and zoster represent typical laboratory features of multiple sclerosis and occurs rather independently of disease duration and is usually other inflammatory and infectious diseases of the CNS. The present at the onset of disease (Reiber et al., 1998) . antigen specificity of the oligoclonal IgGs in multiple sclerosis Two patients [one with probable multiple sclerosis (PoVe) is largely unknown. In the case of infectious CNS disease, and one with definite CP-multiple sclerosis (LuAl)] showed at least part of the intrathecally produced oligoclonal IgG is a few oligoclonal bands specific to C. pneumoniae in both directed to the specific pathogen. This has been reported for serum and CSF. However, a highly sensitive detection system different virus infections of the CNS (Dörries and ter Meulen, was required to demonstrate this reaction. The ELISA results 1984), B. burgdorferi and neuroborreliosis (Martin et al., indicate that these two patients had a rather high concentration 1988), and other infections of the CNS (reviewed by Gilden, of IgGs against C. pneumoniae in both serum and CSF. 1999). Furthermore, the oligoclonal IgGs in the CSF are Importantly, they did not show a specific intrathecal IgG temporally stable in multiple sclerosis patients, suggesting production to C. pneumoniae (AI Ͻ 2). The finding that that they are caused by a specific and chronic activation of these two patients showed C. pneumoniae-specific oligoclonal B cells (Walsh and Tourtellotte, 1986) , presumably by an bands in the CSF and serum by IEF-western blot validates antigen-driven response (Smith-Jensen et al., 2000) . Therethis analysis. However, since these two patients did not fore, we tested whether the oligoclonal IgGs present in display an intrathecal IgG production to C. pneumoniae, multiple sclerosis CSF were specific for C. pneumoniae. For there is no evidence that this agent is causally related to comparison, we analysed paired CSF-serum samples from their disease. patients with neuroborreliosis and determined the reactivity In a recent paper, which was accompanied by several of their oligoclonal bands to the specific pathogen of this critical editorials, Yao et al. (2001) reported that CSF disease, B. burgdorferi.
oligoclonal bands include antibodies to C. pneumoniae. The IEF-western blot experiments revealed that the major Reactivity to C. pneumoniae was detected in 16 out of oligoclonal IgG bands in the CSF of multiple sclerosis 16 multiple sclerosis patients by IEF-western. Oligoclonal patients did not react with C. pneumoniae. In contrast, all bands were adsorbed either partially or completely with four control patients with neuroborreliosis analysed showed C. pneumoniae in 14 out of 17 patients (Yao et al., 2001 ). a strong intrathecal IgG production against B. burgdorferi
Presently the discrepancy between their and our results and strong reactivity of oligoclonal bands to this bacterium remains unresolved. We note, however, the following points. detectable by IEF-western blot.
(i) Yao et al. did not report any ELISA results to quantify What might be the reason for the strong reactivity of CSF intrathecal IgG production to C. pneumoniae. In our study, oligoclonal IgGs of neuroborreliosis patients to B. burgdorferi the seropositivity to C. pneumoniae (42-70%) was similar on the one hand and lack of reactivity of the major oligoclonal in multiple sclerosis patients and controls, in agreement with IgGs of multiple sclerosis patients to C. pneumoniae on the another recent report (Krametter et al., 2001 et al., 2000) to quantify intrathecal IgG production of subacute sclerosing panencephalitis (Conrad et al., 1994) .
to C. pneumoniae.
(ii) The 100% IEF-western reactivity to In contrast, the concentration of those IgGs that belong to C. pneumoniae described by Sriram et al. (1999) is the polyspecific immune response, such as IgGs directed to surprisingly high. The discrepancy with our findings could measles, rubella and zoster virus, represent together only be related to different antigen preparations and different 2% of the IgG in the CSF (Reiber et al., 1998) . In addition, technical details of the IEF-western procedure. Yao et al. the intrathecal polyspecific IgG in multiple sclerosis is usually found a surprisingly high reactivity not only to C. pneumoniae of low affinity, in contrast to the IgG directed against a but also to other (control) antigens. In Table 1 of their paper, specific pathogen (Luxton et al., 1995) . Both the low affinity 10 multiple sclerosis patients were analysed by IEF-western and lower concentration of the anti-C. pneumoniae IgGs in for both measles and HSV-1 as control antigens. Seven to multiple sclerosis as compared with the anti-Borrelia IgGs eight of these patients responded to either measles or HSVin neuroborreliosis might account for the weak reactivity to 1. This might indicate a lower stringency of their IEF-western C. pneumoniae in the affinity-mediated IEF-western blot.
protocol. (iii) The adsorption experiments of Yao et al. (2000) Our finding that the major oligoclonal IgGs in the CSF of are difficult to interpret because the Chlamydia-adsorbed multiple sclerosis patients are not directed against samples were not tested against control antigens to C. pneumoniae argues that the intrathecal IgG production against C. pneumoniae in a subgroup of multiple sclerosis is demonstrate selective loss of anti-C. pneumoniae reactivity.
production in eight out of 22 multiple sclerosis patients
Weak reactivity in IEF-western blot in special (36%) (no data about control patients were reported) and cases initiated a placebo-controlled multicentre study to evaluate One patient without evidence of an inflammatory CNS disease the efficiency of an antibiotic treatment with roxithromycin showed an intrathecal IgG production to C. pneumoniae and (Treib et al., 2000) . In contrast, however, another group C. pneumoniae-specific oligoclonal bands in the IEF-western detected C. pneumoniae in a high percentage of the CSF of blot analysis detected in both serum and CSF. This might both multiple sclerosis patients and controls (Li et al., 2000) . seem surprising, but it has been reported that an intrathecal Yet another study detected C. pneumoniae in the CSF by IgG synthesis develops in 5-10% of patients with non-PCR in 21% of multiple sclerosis patients and in 43% of inflammatory neurological diseases (Tourtellotte and Tumani, controls (Gieffers et al., 2001 ). We did not find reproducible 1997). An intrathecal IgG synthesis in patients presenting evidence for the presence of the C. pneumoniae genome in with non-inflammatory neurological diseases frequently is any of the 23 CSF samples studied. The diverging results of regarded as an immune scar, since an intrathecal IgG synthesis previous PCR studies may depend on cell number, CSF persists for many years after overcoming encephalitis or amount, handling of the probe and the specific PCR protocol. meningitis.
Still, one must consider that a negative PCR by no means Another patient, who had limbic encephalitis of excludes an involvement of C. pneumoniae, since it has unidentified origin, showed an intrathecal IgG production to been established that in another chronic CNS disease, C. pneumoniae and C. pneumoniae-specific oligoclonal bands neuroborreliosis, B. burgdorferi can be detected by PCR in exclusively in the CSF, but not in the serum. The CSF of only~17% of the patients (Lebech et al., 2000) . this patient did not contain C. pneumoniae detectable by For these reasons, we focused our study not on PCR or PCR. It should be noted that the reactivity to C. pneumoniae culture, but rather on the IgG response in the CSF and in by IEF-western blot was much weaker than the reactivity of serum. IgG is stable outside the body and the results are not the neuroborreliosis patients to B. burgdorferi and required a affected by the amount of CSF obtained or the speed highly sensitive detection method. It remains to be established of further processing. Most importantly, it has been well whether in this single case of encephalitis of unknown origin established that oligoclonal bands specific for the respective C. pneumoniae plays a pathogenic role. This patient recovered pathogen arise in all kinds of infectious CNS diseases without any specific therapy. (Gilden, 1999) .
Taken together, our study shows that a subgroup of~25%
PCR results and comparison of our data with of multiple sclerosis patients produces intrathecal IgGs against previous reports C. pneumoniae. Importantly, even in this fraction of multiple Different approaches including the culture of C. pneumoniae sclerosis patients, the major oligoclonal IgGs in the CSF do and PCR analysis of the CSF and autoptic brain have been not recognize C. pneumoniae. This argues strongly against a undertaken to analyse a potential role for C. pneumoniae in pathogenic role for this agent in multiple sclerosis. the pathogenesis of multiple sclerosis. The detection of C. pneumoniae by culture is difficult and not very sensitive,
